Efficacy of different high dose rate interstitial brachytherapy for tongue cancer: a systematic review

Alzahrani R, Obaid A, Al-Hakami H, Alshehri A, Al-Assaf H, Adas R, Alduhaibi E, Alsafadi N, Alghamdi S. Alghamdi M. Locally advanced oral cavity cancers: what is the optimal care?? Cancer Control. 2020;27:1–11.

Article  Google Scholar 

Deneuve S, Guerlain J, Dupret-Bories A, et al. Oral tongue squamous cell carcinomas in young patients according to their smoking status: a GETTEC study. Eur Arch Otorhinolaryngol. 2022;279:415–24.

Article  Google Scholar 

Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol. 2008;9:667–75.

Article  Google Scholar 

Patel SC, Carpenter WR, Tyree S, et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol. 2011;29:1488–94.

Article  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, Jemal A, Cancer Statistics. CA Cancer J Clin. 2021;71(1):7–33. https://doi.org/10.3322/caac.21654. Epub 2021 Jan 12. Erratum in: CA Cancer J Clin. 2021; 71(4):359.

Barnes L, Eveson J, Reichart P, Sidransky D. World health organization classifications tumours. Pathology and genetics of head and neck tumours 2005; Lyon: IARC.

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. https://doi.org/10.1016/j.cell.2011.02.013.

Article  Google Scholar 

Yanamoto S, Yamada S, Takahashi H, et al. Predictors of locoregional recurrence in T1–2N0 tongue cancer patients. Pathol Oncol Res. 2013;19:795–803.

Article  Google Scholar 

Lang K, Baur M, Held T, Shafie RE, Moratin J, Freudlsperger C, Zaoui K, Bougatf N, Hoffmann J, Plinkert PK, Debus J, Adeberg S. Definitive radiotherapy for squamous cell carcinoma of the oral cavity: a single-institution experience. Radiol Oncol. 2021;19(554):467–73.

Article  Google Scholar 

Alva RC, Koushik ASK, Sweta B, et al. Brachytherapy for oral cavity cancers in the era of Intensity-Modulated radiotherapy: save it or shelve it. Indian J Surg Oncol. 2020;11:406–11.

Article  Google Scholar 

Bhalavat R, Pareek V, Chandra M, Nellore L, George K, Borade D, Kalariya K, Moosa Z, Srivastava A, Reddy N, Kapoor A, Kawale D, Bauskar PN. High-dose-rate interstitial brachytherapy in recurrent head and neck cancer: an effective salvage option. J Contemp Brachytherapy. 2018;10(5):425–30. https://doi.org/10.5114/jcb.2018.78995.

Article  Google Scholar 

Chopra S, Gupta T, Agarwal JP, et al. Re-irradiation in the management of isolated neck recurrences: current status and recommendations. Radiother Oncol. 2006;81:1–8.

Article  Google Scholar 

Tselis N, Ratka M, Vogt HG, et al. Hypofractionated accelerated CT-guided interstitial 192Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol. 2011;98:57–62.

Article  Google Scholar 

Guedea F, Venselaar J, Hoskin P, et al. Patterns of care for brachytherapy in europe: updated results. Radiother Oncol. 2010;97:514–20.

Article  Google Scholar 

Yamazaki H, Yoshida K, Yoshioka Y, Shimizutani K, Furukawa S, Koizumi M, Ogawa KJ. High dose rate brachytherapy for oral cancer. Radiat Res. 2013;54:1–17. https://doi.org/10.1093/jrr/rrs103.

Article  Google Scholar 

Takácsi-Nagy Z, Ferenczi Ö, Major T, et al. Results of sole postoperative interstitial, high-dose-rate brachytherapy of T1-2 tongue tumours. Strahlenther Onkol. 2022;198(9):812–9. https://doi.org/10.1007/s00066-022-01901-w.

Article  Google Scholar 

Tuček L, Vošmik M, Petera J. Is there still a place for brachytherapy in the modern treatment of Early-Stage oral cancer?? Cancers (Basel). 2022;14(1):222. https://doi.org/10.3390/cancers14010222.

Article  Google Scholar 

Kissel M, Créhange G, Graff P. Stereotactic radiation therapy versus brachytherapy: relative strengths of two highly efficient options for the treatment of localised prostate Cancer. Cancers. 2022;14(9):2226. https://doi.org/10.3390/cancers14092226.

Article  Google Scholar 

Tanderup K, Ménard C, Polgar C, Christian C, Lindegaard JC, Kirisits C, Pötter R. Advancements in brachytherapy. Adv Drug Deliv Rev. 2017;109:15–25.

Article  Google Scholar 

Holschneider CH, Petereit DG, Chu C, Hsu I, Ioffe YJ, Klopp AH, Pothuri B, Chen L, Yashar C, Brachytherapy. A critical component of primary radiation therapy for cervical cancer: from the society of gynecologic oncology (SGO) and the American brachytherapy society (ABS). Gynecol Oncol. 2019;152:3540–547.

Narayana A, Cohen GN, Zaider M, et al. High-dose rate brachytherapy in recurrent and previously irradiated head and neck cancers-preliminary results. Brachytherapy. 2007;6:157–63.

Article  Google Scholar 

Martell K, Kollmeier MA. Complications and side effects of high-dose-rate prostate brachytherapy. Brachytherapy. 2021;20(5):966–75. https://doi.org/10.1016/j.brachy.2020.10.007.

Article  Google Scholar 

Mazeron JJ, Ardiet JM, Haie-Méder C, et al. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol. 2009;91:150–6.

Article  Google Scholar 

Nag S, Cano ER, Demanes, et al. The American brachytherapy society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2001;50:1190–8.

Bansal A, Ghoshal S, Oinam AS, Sharma SC, Dhanireddy B, Kapoor R. High-dose-rate interstitial brachytherapy in early stage oral tongue cancer– 15 year experience from a tertiary care Institute. J Cont Brachytherapy. 2016;8(1):56–65. https://doi.org/10.5114/jcb.2016.58082.

Article  Google Scholar 

Santos M, Guinot JL, Tortajada M, et al. Is perioperative brachytherapy effective in carcinoma of the tongue? J Contemp Brachytherapy. 2022;14(1):23–8. https://doi.org/10.5114/jcb.2022.113425.

Article  Google Scholar 

Takácsi-Nagy Z, Oberna F, Polgár C, Somogyi A, Major T, Németh G. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis. Neoplasma. 2001;48(1):76–81.

Google Scholar 

Guinot JL, Santos M, Tortajada MI, et al. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma. Brachytherapy. 2010;9(3):227–34. https://doi.org/10.1016/j.brachy.2009.10.003.

Article  Google Scholar 

Matsumoto K, Sasaki T, Shioyama Y, et al. Treatment outcome of high-dose-rate interstitial radiation therapy for patients with stage I and II mobile tongue cancer. Jpn J Clin Oncol. 2013;43(10):1012–7. https://doi.org/10.1093/jjco/hyt1081.

Article  Google Scholar 

Ohga S, Uehara S, Miyoshi M et al. High-dose-rate brachytherapy with local injection of bleomycin for N0 oral tongue cancer– possibilities of the control of tumor implant by inserting applicators and the decrease in tumor dose. Nihon Igaku Hoshasen Gakkai Zasshi, 2003; 63(47–50.

Google Scholar 

Sresty NV, Ramanjappa T, Raju AK, et al. Acquisition of equal or better planning results with interstitial brachytherapy when compared with intensity-modulated radiotherapy in tongue cancers. Brachytherapy. 2010;9:235–8. https://doi.org/10.1016/j.brachy.2009.05.006.

Article  Google Scholar 

Erickson BA, Demanes DJ, Ibbott GS, et al. American society for radiation oncology (ASTRO) and American college of radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2011;79:641–9. https://doi.org/10.1016/j.ijrobp.2010.08.046.

Article  Google Scholar 

Kakimoto N, Inoue T, Inoue T, et al. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer. Radiother Oncol. 2003;68(2):123–8. https://doi.org/10.1016/s0167-8140(03)00055-0.

Article  Google Scholar 

Barrett WL, Gluckman JL, Wilson KM, Gleich LL. A comparison of treatments of squamous cell carcinoma of the base of tongue: surgical resection combined with external radiation therapy, external radiation therapy alone, and external radiation therapy combined with interstitial radiation. Brachytherapy. 2004;3(4):240–5. https://doi.org/10.1016/j.brachy.2004.09.002.

Article  Google Scholar 

Karakoyun-Celik O, Norris CM Jr, Tishler R, et al. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Head Neck. 2005;27(5):353–61. https://doi.org/10.1002/hed.20171.

Article  Google Scholar 

Al-Mamgani AA, Levendag PC, Rooij PV, Meeuwis CA, Sewnaik A, Teguh DN. Intensity-modulated radiotherapy followed by a brachytherapy boost for oropharyngeal cancer. Head & Neck, 2013;35.

Chakrabarti B, Ghorai S, Basu B, et al. Late nodal metastasis in early-stage node-negative oral cavity cancers after successful sole interstitial brachytherapy: an institutional experience of 42 cases in India. Brachytherapy. 2010;9(3):254–9. https://doi.org/10.1016/j.brachy.2009.11.001.

Article  Google Scholar 

Yuen PW, Lam KY, Chan AC, et al. Clinicopathological analysis of local spread of carcinoma of the tongue. Am J Surg. 1998;175:242–4.

Article  Google Scholar 

Loree TR, Strong EW. Significance of positive margins in oral cavity squamous carcinoma. Am J Surg. 1990;160:410–4.

Article  Google Scholar 

Sutton DN, Brown JS, Rogers SN, et al. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2003;32:30–4.

Article  Google Scholar 

Slootweg PJ, Hordijk GJ, Schade Y, et al. Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. Oral Oncol. 2002;38:500–3.

Article  Google Scholar 

Chandu A, Adams G, Smith AC. Factors affecting survival in patients with oral cancer: an Australian perspective. Int J Oral Maxillofac Surg. 2005;34:514–20.

Article  Google Scholar 

Jones AS, Bin Hanafi Z, Nadapalan V, et al. Do positive resection margins after ablative surgery for head Aland neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery. Br J Cancer. 1996;74:128–32.

Article  Google Scholar 

Nason RW, Binahmed A, Pathak KA, et al. What is the adequate margin of surgical resection in oral cancer? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:625–9.

Article  Google Scholar 

Mohamad I, Prabhash K, Busheri A, Lai SY, Noronha V, Hosni AH. Current treatment strategies and risk stratification for oral carcinoma. Am Soc Clin Oncol Educ. 2023;43:e389810. https://doi.org/10.1200/EDBK_389810.

Article 

Comments (0)

No login
gif